Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
DM004
i
Other names:
DM004, BCG013
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Biocytogen, Doma Pharma
Drug class:
c-MET-targeted antibody-drug conjugate, 5T4-targeted antibody-drug conjugate
Related drugs:
‹
ABBV-399 (11)
HRA00129-C004 (3)
REGN5093-M114 (3)
SHR-A1403 (3)
ABBV-400 (3)
BYON3521 (2)
DM005 (2)
MYTX-011 (2)
TR1801-ADC (2)
AZD9592 (2)
RC108 (0)
ASN004 (4)
PF-06263507 (1)
naptumomab estafenatox (0)
SYD1875 (0)
ABBV-399 (11)
HRA00129-C004 (3)
REGN5093-M114 (3)
SHR-A1403 (3)
ABBV-400 (3)
BYON3521 (2)
DM005 (2)
MYTX-011 (2)
TR1801-ADC (2)
AZD9592 (2)
RC108 (0)
ASN004 (4)
PF-06263507 (1)
naptumomab estafenatox (0)
SYD1875 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
TPBG expression + MET expression
Lung Cancer
TPBG expression + MET expression
Lung Cancer
DM004
Sensitive: D – Preclinical
DM004
Sensitive
:
D
DM004
Sensitive: D – Preclinical
DM004
Sensitive
:
D
TPBG expression + MET expression
Gastric Cancer
TPBG expression + MET expression
Gastric Cancer
DM004
Sensitive: D – Preclinical
DM004
Sensitive
:
D
DM004
Sensitive: D – Preclinical
DM004
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login